Search

Saved articles

You have not yet added any article to your bookmarks!

Newsletter image

Subscribe to the Newsletter

Join 10k+ people to get notified about new posts, news and tips.

Do not worry we don't spam!

FDA Conducts Safety Evaluation of RSV Antibody Treatments for Infants

FDA Conducts Safety Evaluation of RSV Antibody Treatments for Infants

Post by : Badri Ariffin

The U.S. Food and Drug Administration has initiated a safety evaluation of two injectable treatments aimed at safeguarding infants and toddlers against respiratory syncytial virus (RSV), a prevalent yet potentially dangerous virus that results in hospital visits for thousands of young children annually.

Manufactured by Merck and Sanofi, these long-acting antibody therapies are not vaccines, but serve as crucial protection for infants and toddlers. Officials noted that this review is part of a routine assessment to guarantee the ongoing safety of these medications for general use.

While RSV generally manifests as mild, cold-like symptoms in healthy individuals, it can escalate to serious respiratory conditions in infants, young children, and older adults. Vaccines for older patients and pregnant women have already received FDA approval; however, these antibody shots remain the primary preventive measure available for infants.

Merck’s Enflonsia injection is typically given prior to or during an infant’s first RSV season, which lasts about five months. Meanwhile, Sanofi’s Beyfortus has been administered to over six million children around the globe. Both companies have indicated that no new safety issues have been reported from clinical trials or post-market evaluations.

The CDC has previously advised administering antibody shots to infants born just before or during RSV season, especially if the mother did not get vaccinated in late pregnancy. Additional recommendations apply to certain high-risk children aged 8 to 19 months.

This safety review unfolds amidst a wider examination of vaccine and drug safety protocols under Health Secretary Robert F. Kennedy Jr., who has recently made changes to the CDC's advisory committee and is considering adjustments to routine hepatitis B vaccinations for newborns.

FDA officials clarified that this review does not imply any confirmed safety problems. Depending on the outcomes of ongoing assessments, there may be updates to the product labeling.

Dec. 10, 2025 12:54 p.m. 394

#Global News #Business News

Klang Flash Floods Disrupt Traffic Across Selangor, Malaysia
Nov. 18, 2026 11:37 a.m.
Heavy rain causes Klang flash floods, disrupting traffic in Bukit Raja and Shah Alam as motorists face delays across Selangor, Malaysia
Read More
Xi Jinping Urges Asia-Pacific Nations to Remove Trade Barriers
Nov. 18, 2026 10:20 a.m.
Xi Jinping urges Asia-Pacific economies to remove trade barriers, boost investment and strengthen regional stability at the APEC Summit in China
Read More
Singapore Reviews New US Chip Export Controls Targeting China
Nov. 17, 2026 11:34 a.m.
Singapore reviews US chip export restrictions targeting China's AI access, raising concerns for semiconductor trade and data centre businesses
Read More
APEC Members Emphasise Safe and Responsible Use of Artificial Intelligence
Nov. 17, 2026 10:24 a.m.
APEC members discuss responsible AI use, digital innovation and data governance as China and the US compete for global AI leadership
Read More
Union of European Clubs Challenge UEFA and EFC Over EU Competition Rules
Nov. 16, 2026 5:18 p.m.
UEC files an EU competition complaint against UEFA and EFC, challenging club representation, governance rights and decision-making powers
Read More
US Dollar Extends Rally as Yen Faces Pressure After Weak GDP
Nov. 16, 2026 4:29 p.m.
The US dollar reaches a 19-month high as traders assess Fed rate signals, weak Japan GDP data and possible yen intervention
Read More
Sheikh Hasina Plans December Return to Bangladesh Despite Death Threat
Nov. 16, 2026 3:35 p.m.
Sheikh Hasina plans to return to Bangladesh in December despite death threats, a death sentence and growing political tensions with Dhaka
Read More
Trump Plans to Name Nvidia and AI Firms US National Champions
Nov. 16, 2026 10:01 a.m.
Trump administration plans to name Nvidia, Amazon, Microsoft and OpenAI among US AI national champions to expand overseas and compete with China
Read More
Mohammed Shami Retires From Test Cricket, Eyes White-Ball Career
Nov. 7, 2026 11:10 a.m.
Mohammed Shami retires from Test cricket after 13 years, with 229 wickets. He will continue playing white-ball cricket and domestic matches
Read More
Trending News